2007
DOI: 10.2170/physiolsci.sc003007
|View full text |Cite
|
Sign up to set email alerts
|

A Novel Inhibitor of Hypertonicity-Induced Cation Channels in HeLa Cells

Abstract: Despite the paramount significance of hypertonicityinduced cation channels (HICCs) in cell proliferation and apoptosis, a detailed analysis of these processes is hindered by the very limited number of HICC blockers available. Here, 2-aminoethoxydiphenyl borate (2-APB) is introduced as a novel and effective inhibitor of the HICC in HeLa cells. Its efficiency is defined with reference to flufenamic acid (as the most potent blocker so far), both, in whole-cell patch-clamp recordings and in measurements of cell vo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2008
2008
2023
2023

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 16 publications
0
3
0
Order By: Relevance
“…By contrast, mefenamic acids such as tolfenamic acid, flufenamic acid, niflumic acid, meclofenamic acid and DCDPC (3′‐5‐dichlorodiphenylamine‐2‐carboxylic acid) have also been described to modulate a variety of ion channels and enzymes (Gögelein et al ., 1990; Kankaanranta and Moilanen, 1995; Vietri et al ., 2000; Guinamard et al ., 2004; Dvorzhak, 2008; Habjan and Vandenberg, 2009). The use of fenamates to interfere with cellular volume regulation (Jin et al ., 2003; Lambert and Oberwinkler, 2005; Ducharme et al ., 2007; Numata et al ., 2007) as well as reports describing flufenamic acid as a blocker of transient receptor potential (TRP) channels attracted our interest to this group of small compounds (Tesfai et al ., 2001; Lee et al ., 2003; Guinamard et al ., 2004; Hill et al ., 2004; Guilbert et al ., 2009). In fact, the use of flufenamic acid is increasing because of the absence of selective and potent drugs or pharmacological tools to interfere with TRP channel activity.…”
Section: Introductionmentioning
confidence: 99%
“…By contrast, mefenamic acids such as tolfenamic acid, flufenamic acid, niflumic acid, meclofenamic acid and DCDPC (3′‐5‐dichlorodiphenylamine‐2‐carboxylic acid) have also been described to modulate a variety of ion channels and enzymes (Gögelein et al ., 1990; Kankaanranta and Moilanen, 1995; Vietri et al ., 2000; Guinamard et al ., 2004; Dvorzhak, 2008; Habjan and Vandenberg, 2009). The use of fenamates to interfere with cellular volume regulation (Jin et al ., 2003; Lambert and Oberwinkler, 2005; Ducharme et al ., 2007; Numata et al ., 2007) as well as reports describing flufenamic acid as a blocker of transient receptor potential (TRP) channels attracted our interest to this group of small compounds (Tesfai et al ., 2001; Lee et al ., 2003; Guinamard et al ., 2004; Hill et al ., 2004; Guilbert et al ., 2009). In fact, the use of flufenamic acid is increasing because of the absence of selective and potent drugs or pharmacological tools to interfere with TRP channel activity.…”
Section: Introductionmentioning
confidence: 99%
“…TRPM2 currents are blocked by an antipyretic acid-derivative nonsteroidal anti-inflammatory drug (NSAID), flufenamic acid (FFA), at 50–1000 μM with an IC 50 of 70 μM ( Hill et al, 2004a ). FFA also inhibits HICC/TRPM2-∆C activity ( Wehner et al, 2003b ) with an IC 50 of 117 μM ( Numata et al, 2007c ). However, it must be noted that FFA affects not only TRPM2 but also other ion channels including some chloride, sodium, potassium and calcium channels ( Guinamard et al, 2013 ).…”
Section: Phenotypic Properties and Molecular Structures Of Trpm2 And ...mentioning
confidence: 99%
“…FFA analogs, mefenamic acid (MFA) and niflumic acid (NFA), are also effective to inhibit TRPM2 channels with IC 50 values of 76 and ∼120 μM, respectively ( Chen et al, 2012 ). Another fenamate analog, 2-aminoethoxydiphenyl borate (2-APB), suppresses TRPM2 activity with an IC 50 of 1.2 μM ( Togashi et al, 2008 ) and HICC activity with an IC 50 of 525 μM ( Numata et al, 2007c ). 2-APB is not specific for TRPM2, because it also inhibits other TRPM members ( Togashi et al, 2008 ) including TRPM7 ( Li et al, 2006 ) and multiple TRPC channels ( Xu et al, 2005 ) but activates several TRPV channels ( Hu et al, 2004 ).…”
Section: Phenotypic Properties and Molecular Structures Of Trpm2 And ...mentioning
confidence: 99%